Edition:
India

GlaxoSmithKline PLC (GSK.N)

GSK.N on New York Stock Exchange

44.45USD
12:42am IST
Change (% chg)

$0.12 (+0.27%)
Prev Close
$44.33
Open
$44.63
Day's High
$44.69
Day's Low
$44.29
Volume
295,695
Avg. Vol
497,471
52-wk High
$46.01
52-wk Low
$36.42

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 7,809.00 0.193
Mar '19 7,661.00 0.167
FY 2018 Dec '18 8,197.00 0.269
Sep '18 8,092.00 0.285
Jun '18 7,310.00 0.089
Mar '18 7,222.00 0.111
FY 2017 Dec '17 7,639.00 0.109
Sep '17 7,843.00 0.246
Jun '17 7,320.00 -0.037
Mar '17 7,384.00 0.214
 
*Note: Units in Millions ofBritish Pounds
**Note: Units in British Pounds

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-19 2 10,631.50 11,057.90 10,205.20 10,391.50
Quarter Ending Mar-20 1 10,498.40 10,498.40 10,498.40 --
Year Ending Dec-19 3 41,164.20 43,195.00 39,969.80 40,542.00
Year Ending Dec-20 3 45,100.90 46,509.30 43,829.20 41,889.50
Earnings (per share)
Quarter Ending Dec-19 1 0.58 0.58 0.58 --
Year Ending Dec-19 3 2.88 2.98 2.77 2.90
Year Ending Dec-20 3 3.04 3.15 2.89 --
LT Growth Rate (%) 1 8.90 8.90 8.90 8.80
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 18.89 29.73 33.85
P/E High - Last 5 Yrs. 83.92 47.56 54.29
P/E Low - Last 5 Yrs. 7.83 27.30 28.22
Beta 0.72 1.00 0.99
Price to Sales (TTM) 2.75 6.00 7.90
Price to Book (MRQ) 23.83 3.84 4.38
Price to Tangible Book (MRQ) -- 4.14 5.07
Price to Cash Flow (TTM) 10.78 21.62 23.70
% Owned Institutions 11.50 0.79 1.78

Dividends

  Company industry sector
Dividend Yield 4.87 1.83 1.67
Dividend Yield - 5 Year Avg 5.65 1.47 1.37
Dividend 5 Year Growth Rate 0.51 6.74 6.82
Payout Ratio(TTM) 66.06 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 6.83 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago 5.81 6.45 8.45
Sales - 5 Yr. Growth Rate 3.06 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 117.29 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago 64.88 -- --
EPS - 5 Yr. Growth Rate -7.36 5.66 7.15
Capital Spending - 5 Yr. Growth Rate 1.09 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.48 2.52 2.52
Current Ratio (MRQ) 0.71 3.55 3.52
LT Debt to Equity (MRQ) 645.07 11.64 12.61
Total Debt to Equity (MRQ) 925.84 16.17 17.64
Interest Coverage (TTM) 13.09 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 68.53 51.41 50.25
Gross Margin - 5 Yr. Avg. 68.44 50.53 51.36
EBITD Margin (TTM) 35.91 -- --
EBITD - 5 Yr. Avg 33.18 17.64 16.42
Operating Margin (TTM) 20.09 -2.19 -6.97
Operating Margin - 5 Yr. Avg. 19.90 13.94 11.87
Pre-Tax Margin (TTM) 17.75 -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. 17.49 18.73 15.72
Net Profit Margin (TTM) 15.66 -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. 14.49 14.06 11.11
Effective Tax Rate (TTM) 11.81 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. 17.15 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) 406,326 1,012,949,194 870,638,159
Net Income/Employee (TTM) 63,612 118,477,208 101,855,832
Receivable Turnover (TTM) 4.73 5.61 5.88
Inventory Turnover (TTM) 1.68 2.59 3.66
Asset Turnover (TTM) 0.52 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 8.20 10.57 10.25
Return on Assets - 5 Yr. Avg. 7.58 11.70 11.17
Return on Investment (TTM) 12.65 13.04 12.69
Return on Investment - 5 Yr. Avg. 12.51 14.80 14.15
Return on Equity (TTM) 124.83 14.12 17.13
Return on Equity - 5 Yr. Avg. 114.50 15.92 15.53
  1 Year 3 Year 5 Year
Sales % 2.10 8.81 3.06
EPS (TTM) % 42.74 -24.08 -7.36
Dividend % 0.00 0.00 0.51
Note: Units in Millions of US Dollars

Performance for GlaxoSmithKline PLC

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 4.72 1.81 99 47
13 Week 3.74 0.79 99 34
26 Week 9.08 -3.93 99 15
52 Week 3.84 -2.63 99 66
YTD 9.68 -9.13 99 20
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 11.50%
# of Holders: 906
Total Shares Held: 286,800,420
3 Mo. Net Change: -211,150
# New Positions: 13
# Closed Positions: 29
# Increased Positions: 89
# Reduced Positions: 104
# Net Buyers: -15
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.